LexaGene Life Sciences
Early Stage
THE NEXT FRONTIER FOR TIMELY PATHOGEN AND BIOLOGICAL CONTAMINATION DETECTION
Overview
Raised: $107,120
Total Commitments ($USD)
Platform
Dealmaker Securities
Start Date
10/31/2023
Close Date
10/31/2024
Min. Goal
$25,750
Max. Goal
$5,000,000
Min. Investment
$1,030
Security Type
Equity - Common
Series
Pre-Seed
SEC Filing Type
RegCF
Price Per Share
$1.03
Rolling Commitments ($USD)
Status
Not Funded
Reporting Date
12/14/2023
Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise
$293
# of Investors
4
Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2023
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
LexaGene Life Sciences is raising funds on Dealmaker Securities. The company is pioneering the technology that provides timely and automated detection of pathogen and bacterial contaminants. LexaGene Life Sciences’ system, MiQLab, is about 300 times faster than the conventional methods and can tap into both biopharma production and veterinary diagnostics. The system is highly accurate and can give results in two hours compared to the 28 days of older methods. Dr. Jack Regan founded LexaGene Life Sciences in August 2023. The current crowdfunding campaign has a minimum target of $25,750 and a maximum target of $5 million. The campaign proceeds will be used for enhancements to the system, hiring, and marketing.
Summary Profit and Loss Statement
| FY 2022 | FY 2021 | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$11,433 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$11,433 |
$0 |
Summary Balance Sheet
| FY 2022 | FY 2021 | |
|---|---|---|
|
Cash |
$1,000 |
$0 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$64,620 |
$0 |
|
Short-Term Debt |
$0 |
$0 |
|
Long-Term Debt |
$0 |
$0 |
|
Total Liabilities |
$0 |
$0 |
Financials as of: 10/31/2023
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.